Adverum Biotechnologies I... (ADVM)
4.16
-0.55 (-11.68%)
At close: Mar 03, 2025, 3:59 PM
4.16
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST
Adverum Biotechnologies Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 75M | 68.43M | 34.2M | 62.42M | 65.9M | 154.95M | 70.52M | 222.17M | 259.08M | 159.4M | 564K | 357K |
| Short-Term Investments | 21.53M | 117.16M | 270.99M | 367.31M | 100.14M | 50.13M | 119.97M | n/a | 37.73M | n/a | n/a | n/a |
| Long-Term Investments | 1.98M | 2.5M | 3.27M | 999K | 999K | 999K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 1.23M | 1.41M | 250K | 29K | 11K | 156K | 140K | 140K | 140K | 543K | 194K | n/a |
| Receivables | n/a | n/a | 5.71M | n/a | n/a | n/a | n/a | 886K | 449K | n/a | 8K | 1K |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 6.25M | 5.01M | 6.25M | 9.42M | 19.67M | 7.35M | 6.51M | 2.22M | 1.46M | 1.75M | 250K | 24K |
| Total Current Assets | 102.77M | 190.59M | 317.14M | 434.44M | 175.87M | 208.75M | 193.74M | 225.27M | 260.99M | 160.28M | 822K | 382K |
| Property-Plant & Equipment | 67.03M | 113.86M | 119.06M | 47.1M | 45.85M | 3.59M | 3.02M | 4.17M | 3.19M | 1.08M | 69K | 4K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 5M | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 70.24M | 117.78M | 122.58M | 48.13M | 46.86M | 4.74M | 8.16M | 9.31M | 3.33M | 1.63M | 263K | 4K |
| Total Assets | 173.01M | 308.37M | 439.73M | 482.57M | 222.73M | 213.5M | 201.91M | 234.58M | 264.32M | 161.91M | 1.08M | 386K |
| Account Payables | 1.92M | 2.24M | 1.39M | 2.81M | 4.1M | 1.71M | 1.73M | 1.47M | 605K | 951K | 769K | 522K |
| Deferred Revenue | n/a | n/a | 16.03M | 12.26M | 8.63M | -100K | 1.85M | 1.85M | 883K | 813K | n/a | n/a |
| Short-Term Debt | 10.41M | 26.48M | 3.77M | 8.95M | 4.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 12.48M | 3.27M | 14.84M | 9.07M | 11.27M | 9.01M | 7.09M | 6.57M | 5.09M | 3.71M | 393K | 317K |
| Total Current Liabilities | 24.91M | 32.25M | 21.32M | 20.87M | 19.41M | 10.72M | 10.67M | 9.9M | 6.57M | 5.47M | 1.16M | 839K |
| Long-Term Debt | 64.63M | 93.56M | 101.11M | 26.23M | 28.21M | 200K | n/a | n/a | n/a | n/a | 91K | 521K |
| Other Long-Term Liabilities | n/a | 1.05M | 1.11M | 1.11M | 148K | 1.41M | 703K | 738K | 447K | 306K | 50K | 23K |
| Total Long-Term Liabilities | 64.63M | 94.61M | 102.22M | 27.35M | 28.36M | 1.61M | 7.2M | 9.09M | 5.15M | 6.95M | 141K | 544K |
| Total Liabilities | 89.54M | 126.85M | 123.54M | 48.22M | 47.77M | 12.33M | 17.88M | 18.98M | 11.73M | 12.42M | 1.3M | 1.38M |
| Total Debt | 75.04M | 106.8M | 102.99M | 30.71M | 32.25M | 300K | 400K | n/a | n/a | n/a | n/a | 485K |
| Common Stock | 10K | 10K | 10K | 10K | 7K | 6K | 5K | 4K | 3K | 2K | n/a | n/a |
| Retained Earnings | -919.78M | -802.61M | -648.08M | -502.54M | -385.03M | -320.54M | -254.06M | -197.91M | -84.17M | -36.72M | -8.87M | -3.59M |
| Comprehensive Income | -473K | -1.53M | -714K | -261K | -725K | -799K | -963K | -7K | -11K | 10K | 27K | 8K |
| Shareholders Equity | 83.47M | 181.52M | 316.19M | 434.35M | 174.96M | 201.17M | 184.03M | 215.6M | 252.59M | 149.48M | -218K | -997K |
| Total Investments | 23.5M | 117.16M | 270.99M | 367.31M | 100.14M | 50.13M | 119.97M | n/a | 37.73M | n/a | n/a | n/a |